Efficient synthesis of antiviral agent uprifosbuvir enabled by new synthetic methods

Author:

Klapars Artis1234ORCID,Chung John Y. L.1234ORCID,Limanto John1234,Calabria Ralph1234,Campeau Louis-Charles1234ORCID,Campos Kevin R.1234,Chen Wenyong1234,Dalby Stephen M.1234,Davis Tyler A.1234,DiRocco Daniel A.1234,Hyde Alan M.1234,Kassim Amude M.1234,Larsen Mona Utne1234,Liu Guiquan567,Maligres Peter E.1234,Moment Aaron1234,Peng Feng1234,Ruck Rebecca T.1234ORCID,Shevlin Michael1234,Simmons Bryon L.1234,Song Zhiguo Jake1234,Tan Lushi1234,Wright Timothy J.1234,Zultanski Susan L.1234ORCID

Affiliation:

1. Department of Process Research and Development

2. Merck & Co., Inc.

3. Rahway

4. USA

5. WuXi STA

6. Shanghai 200131

7. China

Abstract

An efficient route to the HCV antiviral agent uprifosbuvir was developed in 5 steps from readily available uridine in 50% overall yield.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Reference32 articles.

1. Approved Antiviral Drugs over the Past 50 Years

2. Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

3. Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches

4. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c

5. HCV: The Journey from Discovery to a Cure , ed. M. J. Sofia , Top. Med. Chem., 2019 , vol. 32

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3